Investigational Site Number : 1000001

Plovdiv 4004

0 studies enrolling now · 2 studies all time

What they study most

Non-small Cell Lung Cancer Metastatic, Type 1 Diabetes Mellitus

Studies at this site

• Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab or Ramucirumab and Pembrolizumab in Pretreated Patients With NSQ NSCLC (CARMEN-LC04) — Stopped early
• Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus — Completed